tokyo

HeartCore Signs 15th Go IPO Contract

June 03, 2025 16:30 ET  | Source: HeartCore Enterprises Inc. NEW YORK and TOKYO, June 03, 2025 (GLOBE NEWSWIRE) --…

2 months ago

DATROWAY Continues to Show Promising Tumor Responses as Part of Combination Regimens in Patients with Early and Advanced Non-Small Cell Lung Cancer

TROPION-Lung02 and TROPION-Lung04 phase 1b results support combination of Daiichi Sankyo and AstraZeneca’s DATROWAY with immunotherapy as first-line treatment for…

2 months ago
Show previous Posts